Journal article
Treatment with granulocyte–macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock
Authors
Schefold JC; Zeden J-P; Pschowski R; Hammoud B; Fotopoulou C; Hasper D; Fusch G; Haehling SV; Volk H-D; Meisel C
Journal
Scandinavian Journal of Infectious Diseases, Vol. 42, , pp. 164–171
Publisher
Informa UK Limited
Publication Date
February 19, 2010
DOI
10.3109/00365540903405768
ISSN
0036-5548
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedCalcitoninCalcitonin Gene-Related PeptideGranulocyte-Macrophage Colony-Stimulating FactorHLA-DR AntigensHumansImmunologic FactorsIndoleamine-Pyrrole 2,3,-DioxygenaseKynurenic AcidKynurenineMaleMiddle AgedPlacebosProtein PrecursorsQuinolinic AcidSepsisSerotoninShock, SepticTreatment OutcomeTryptophan